Andrew von Eschenbach, President Bush's nominee to head the Food and Drug Administration, finally got his chance to make his case before a Senate committee.
But his fate is now wrapped up in a fight over whether to approve over-the-counter access to the so-called morning-after birth-control pill -- as well as broader questions about the intersection of science and politics.
Copyright 2023 NPR. To see more, visit https://www.npr.org.
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.
